Current Status of Bioprinting Using Polymer Hydrogels for the Production of Vascular Grafts
Cardiovascular disease is one of the leading causes of death and serious illness in Europe and worldwide. Conventional treatment—replacing the damaged blood vessel with an autologous graft—is not always affordable for the patient, so alternative approaches are being sought. One such approach is pati...
Saved in:
Main Authors: | Jana Matějková, Denisa Kaňoková, Roman Matějka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Gels |
Subjects: | |
Online Access: | https://www.mdpi.com/2310-2861/11/1/4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polymeric hydrogel nanoparticles in drug delivery and bioprinting technologies: a review
by: Prasanta Kumar Ghosh
Published: (2024-12-01) -
Non-professional phagocytosis of senescent cancer cells revealed in a 3D-bioprinted model of an irradiated lung tumour
by: Parul Yadav, et al.
Published: (2025-12-01) -
Three-Dimensional Bioprinting as a Tool for Tissue Engineering: A Review
by: Sneha C. Dare, et al.
Published: (2024-12-01) -
3D BIOPRINTING IN DENTISTRY: BIBLIOMETRIC ANALYSIS
by: Peter Frantsevich Litvitskiy, et al.
Published: (2024-12-01) -
3D bioprinting for the production of a perfusable vascularized model of a cancer niche
by: Federico Maggiotto, et al.
Published: (2025-01-01)